Abstract
Hematologic malignancies are relatively uncommon neoplasms of abdominal soft tissue. This article discusses the clinical and imaging features of pancreatic lymphoma, pancreatic extraosseous multiple myeloma, granulocytic sarcoma (chloroma), posttransplant lymphoproliferative disorder, and Castleman disease. The combination of imaging findings and the appropriate clinical presentation should allow the radiologist to raise a provisional diagnosis of hematologic malignancy.
Similar content being viewed by others
References
Nayer H, Weir EG, Sheth S, Ali SZ (2004) Primary pancreatic lymphomas: a cytopathologic analysis of a rare malignancy. Cancer 102:315–321
Webb TH, Lillemoe KD, Pitt HA, Jones RJ, Cameron JL (1989) Pancreatic lymphoma. Is surgery mandatory for diagnosis or treatment? Ann Surg 209:25–30
Dawson IM, Cornes JS, Morson BC (1961) Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg 49:80–89
Behrns KE, Sarr MG, Strickler JG (1994) Pancreatic lymphoma: is it a surgical disease? Pancreas 9:662–667
Nishimura R, Takakuwa T, Hoshida Y, Tsujimoto M, Aozasa K (2001) Primary pancreatic lymphoma: clinicopathological analysis of 19 cases from Japan and review of the literature. Oncology 60:322–329
Battula N, Srinivasan P, Prachalias A, Rela M, Heaton N (2006) Primary pancreatic lymphoma: diagnostic and therapeutic dilemma. Pancreas 33:192–194
Bouvet M, Staerkel GA, Spitz FR, et al. (1998) Primary pancreatic lymphoma. Surgery 123:382–390
Fujinaga Y, Lall C, Patel A, et al. (2013) MR features of primary and secondary malignant lymphoma of the pancreas: a pictorial review. Insights Imaging 4:321–329
Ji Y, Kuang TT, Tan YS, et al. (2005) Pancreatic primary lymphoma: a case report and review of the literature. Hepatobiliary Pancreat Dis Int 4:622–626
Lin H, Li SD, Hu XG, Li ZS (2006) Primary pancreatic lymphoma: report of six cases. World J Gastroenterol 12:5064–5067
Merkle EM, Bender GN, Brambs HJ (2000) Imaging findings in pancreatic lymphoma: differential aspects. AJR Am J Roentgenol 174:671–675
Prayer L, Schurawitzki H, Mallek R, Mostbeck G (1992) CT in pancreatic involvement of non-Hodgkin lymphoma. Acta Radiol 33:123–127
Saif MW (2006) Primary pancreatic lymphomas. JOP 7:262–273
Dong A, Cui Y, Gao L, et al. (2013) Patterns of FDG uptake in pancreatic non-Hodgkin’s lymphoma lesions. Abdom Imaging . doi:10.1007/s00261-013-0041-5
Bhosale PR, Menias CO, Balachandran A, et al. (2013) Vascular pancreatic lesions: spectrum of imaging findings of malignant masses and mimics with pathologic correlation. Abdom Imaging 38:802–817
Coakley FV, Hanley-Knutson K, Mongan J, et al. (2012) Pancreatic imaging mimics: part 1, imaging mimics of pancreatic adenocarcinoma. AJR Am J Roentgenol 199:301–308
Suzuki K, Itoh S, Nagasaka T, et al. (2010) CT findings in autoimmune pancreatitis: assessment using multiphase contrast-enhanced multisection CT. Clin Radiol 65:735–743
Ferrozzi F, Bova D, Campodonico F, et al. (1997) Pancreatic metastases: CT assessment. Eur Radiol 7:241–245
Shin JU, Lee JK, Kim KM, et al. (2013) The differentiation of autoimmune pancreatitis and pancreatic cancer using imaging findings. Hepatogastroenterology 60:1174–1181
Chou YH, Chiou HJ, Hong TM, et al. (2002) Solitary metastasis from renal cell carcinoma presenting as diffuse pancreatic enlargement. J Clin Ultrasound 30:499–502
Yang J, Kan Y, Ge BH, et al. (2013) Diagnostic role of gallium-68 DOTATOC and gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis. Acta Radiol . doi:10.1177/0284185113496679
Ishigami K, Tajima T, Nishie A, et al. (2010) MRI findings of pancreatic lymphoma and autoimmune pancreatitis: a comparative study. Eur J Radiol 74:e22–e28
Manfredi R, Frulloni L, Mantovani W, et al. (2011) Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence. Radiology 260:428–436
Cheuk W, Chan JK (2012) Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity. Semin Diagn Pathol 29:226–234
Ganeshan D, Iyer R, Devine C, Bhosale P, Paulson E (2013) Imaging of primary and secondary renal lymphoma. AJR Am J Roentgenol 201:W712–W719
Khalili K, Doyle DJ, Chawla TP, Hanbidge AE (2008) Renal cortical lesions in patients with autoimmune pancreatitis: a clue to differentiation from pancreatic malignancy. Eur J Radiol 67:329–335
Sasiwimonphan K, Gorman B, Kawashima A, Chari ST, Takahashi N (2012) Renal involvement in patients with autoimmune pancreatitis: ultrasound findings. Eur J Radiol 81:807–810
Sheth S, Ali S, Fishman E (2006) Imaging of renal lymphoma: patterns of disease with pathologic correlation. Radiographics 26:1151–1168
Takahashi N, Kawashima A, Fletcher JG, Chari ST (2007) Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 242:791–801
Triantopoulou C, Malachias G, Maniatis P, et al. (2010) Renal lesions associated with autoimmune pancreatitis: CT findings. Acta Radiol 51:702–707
Van Beers B, Lalonde L, Soyer P, et al. (1993) Dynamic CT in pancreatic lymphoma. J Comput Assist Tomogr 17:94–97
Dong A, Dong H, Zhang L, Zuo C (2013) Hypermetabolic lesions of the pancreas on FDG PET/CT. Clin Nucl Med 38:e354–e366
Kaneta T, Hakamatsuka T, Yamada T, et al. (2006) FDG PET in solitary metastastic/secondary tumor of the kidney: a report of three cases and a review of the relevant literature. Ann Nucl Med 20:79–82
Zhang J, Shao C, Wang J, et al. (2013) Autoimmune pancreatitis: whole-body 18F-FDG PET/CT findings. Abdom Imaging 38:543–549
Yoon SN, Lee MH, Yoon JK (2004) F-18 FDG positron emission tomography findings in primary pancreatic lymphoma. Clin Nucl Med 29:574–575
Du X, Zhao Y, Zhang T, et al. (2011) Primary pancreatic lymphoma: a clinical quandary of diagnosis and treatment. Pancreas 40:30–36
Koniaris LG, Lillemoe KD, Yeo CJ, et al. (2000) Is there a role for surgical resection in the treatment of early-stage pancreatic lymphoma? J Am Coll Surg 190:319–330
Freedman A (2012) Follicular lymphoma: 2012 update on diagnosis and management. Am J Hematol 87:988–995
Seiler TM, Hiddemann W (2012) Advances in the management of follicular lymphoma. Curr Opin Oncol 24:742–747
Ujjani C, Cheson BD (2013) The current status and future impact of targeted therapies in non-Hodgkin lymphoma. Expert Rev Hematol 6:191–202; quiz 203
Mishra MV, Keith SW, Shen X, et al. (2013) Primary pancreatic lymphoma: a population-based analysis using the SEER program. Am J Clin Oncol 36:38–43
Izadi M, Fazel M, Saadat SH, Taheri S (2011) Hepatic involvement by lymphoproliferative disorders post liver transplantation: PTLD. International Surveys. Hepatol Int 5:759–766
Green M, Webber S (2003) Posttransplantation lymphoproliferative disorders. Pediatr Clin N Am 50:1471–1491
Jagadeesh D, Woda BA, Draper J, Evens AM (2012) Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations. Curr Treat Options Oncol 13:122–136
Glotz D, Chapman JR, Dharnidharka VR, et al. (2012) The Seville expert workshop for progress in posttransplant lymphoproliferative disorders. Transplantation 94:784–793
Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ (2007) Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Transpl Int 20:207–218
Jeon TY, Kim JH, Eo H, et al. (2010) Posttransplantation lymphoproliferative disorder in children: manifestations in hematopoietic cell recipients in comparison with liver recipients. Radiology 257:490–497
Levy M, Backman L, Husberg B, et al. (1993) De novo malignancy following liver transplantation: a single-center study. Transpl Proc 25:1397–1399
LaCasce AS (2006) Post-transplant lymphoproliferative disorders. Oncologist 11:674–680
Pickhardt PJ, Siegel MJ (1999) Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients. Radiology 213:73–78
Blaes AH, Cioc AM, Froelich JW, Peterson BA, Dunitz JM (2009) Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders. Clin Transpl 23:794–799
Chowdhury FU, Sheerin F, Bradley KM, Gleeson FV (2009) PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD). Clin Nucl Med 34:386–387
Lee EY, Anthony MP, Leung AY, Loong F, Khong PL (2012) Utility of FDG PET/CT in the assessment of myeloid sarcoma. AJR Am J Roentgenol 198:1175–1179
Mantzarides M, Bonardel G, Fagot T, et al. (2008) Granulocytic sarcomas evaluated with F-18-fluorodeoxyglucose PET. Clin Nucl Med 33:115–117
Neiman RS, Barcos M, Berard C, et al. (1981) Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 48:1426–1437
Shinagare AB, Krajewski KM, Hornick JL, et al. (2012) MRI for evaluation of myeloid sarcoma in adults: a single-institution 10-year experience. AJR Am J Roentgenol 199:1193–1198
Paydas S, Zorludemir S, Ergin M (2006) Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma 47:2527–2541
Breccia M, D’Andrea M, Mengarelli A, et al. (2003) Granulocytic sarcoma of the pancreas successfully treated with intensive chemotherapy and stem cell transplantation. Eur J Haematol 70:190–192
Messager M, Amielh D, Chevallier C, Mariette C (2012) Isolated granulocytic sarcoma of the pancreas: a tricky diagnostic for primary pancreatic extramedullary acute myeloid leukemia. World J Surg Oncol 10:13
Rong Y, Wang D, Lou W, Kuang T, Jin D (2010) Granulocytic sarcoma of the pancreas: a case report and review of the literatures. BMC Gastroenterol 10:80
Choi EK, Byun JH, Lee SJ, et al. (2007) Imaging findings of leukemic involvement of the pancreaticobiliary system in adults. AJR Am J Roentgenol 188:1589–1595
Bakst R, Wolden S, Yahalom J (2012) Radiation therapy for chloroma (granulocytic sarcoma). Int J Radiat Oncol Biol Phys 82:1816–1822
Yilmaz AF, Saydam G, Sahin F, Baran Y (2013) Granulocytic sarcoma: a systematic review. Am J Blood Res 3:265–270
Hall MN, Jagannathan JP, Ramaiya NH, Shinagare AB, Van den Abbeele AD (2010) Imaging of extraosseous myeloma: CT, PET/CT, and MRI features. AJR Am J Roentgenol 195:1057–1065
Philips S, Menias C, Vikram R, Sunnapwar A, Prasad SR (2012) Abdominal manifestations of extraosseous myeloma: cross-sectional imaging spectrum. J Comput Assist Tomogr 36:207–212
Oshima K, Kanda Y, Nannya Y, et al. (2001) Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma. Am J Hematol 67:1–5
Varettoni M, Corso A, Pica G, et al. (2010) Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Ann Oncol 21:325–330
Balliu E, Casas JD, Barluenga E, Guasch I (2003) Multifocal involvement of the pancreas in multiple myeloma: sonographic, CT, and MR imaging findings. AJR Am J Roentgenol 180:545–546
Gupta P, Rice GD, Abraham K, Ghole V, Ketkar M (2009) Extramedullary plasmacytoma of the pancreas and jejunum. Clin Imaging 33:240–243
Patlas M, Khalili K, Dill-Macky MJ, Wilson SR (2004) Spectrum of imaging findings in abdominal extraosseous myeloma. AJR Am J Roentgenol 183:929–932
Kazama T, Ng CS, Giralt SA (2005) Multiphasic CT and MRI appearances of extramedullary multiple myeloma involving the stomach, pancreas, and bladder. Clin Imaging 29:263–265
Birjawi GA, Jalbout R, Musallam KM, et al. (2008) Abdominal manifestations of multiple myeloma: a retrospective radiologic overview. Clin Lymphoma Myeloma 8:348–351
Kelekis NL, Semelka RC, Warshauer DM, Sallah S (1997) Nodular liver involvement in light chain multiple myeloma: appearance on US and MRI. Clin Imaging 21:207–209
Moulopoulos LA, Granfield CA, Dimopoulos MA, et al. (1993) Extraosseous multiple myeloma: imaging features. AJR Am J Roentgenol 161:1083–1087
Cerrato C, Palumbo A (2013) Initial treatment of nontransplant patients with multiple myeloma. Semin Oncol 40:577–584
Fonseca R, Monge J (2013) Myeloma: classification and risk assessment. Semin Oncol 40:554–566
Girnius S, Munshi NC (2013) Individualized therapy in multiple myeloma: are we there? Semin Oncol 40:567–576
Moreau P, Touzeau C (2013) Initial treatment of transplant candidates with multiple myeloma. Semin Oncol 40:585–591
Bonekamp D, Horton KM, Hruban RH, Fishman EK (2011) Castleman disease: the great mimic. Radiographics 31:1793–1807
Herrada J, Cabanillas F, Rice L, Manning J, Pugh W (1998) The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 128:657–662
Cronin DM, Warnke RA (2009) Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol 16:236–246
McAdams HP, Rosado-de-Christenson M, Fishback NF, Templeton PA (1998) Castleman disease of the thorax: radiologic features with clinical and histopathologic correlation. Radiology 209:221–228
Charalabopoulos A, Misiakos EP, Foukas P, et al. (2010) Localized peripancreatic plasma cell Castleman disease. Am J Surg 199:e51–e53
Erkan N, Yildirim M, Selek E, Sayhan S (2004) Peripancreatic Castleman disease. JOP 5:491–494
Tunru-Dinh VW, Ghani A, Tom YD (2007) Rare case of Castleman disease involving the pancreas. Am Surg 73:1284–1287
Reddy D, Mitsuyasu R (2011) HIV-associated multicentric Castleman disease. Curr Opin Oncol 23:475–481
Saeed-Abdul-Rahman I, Al-Amri AM (2012) Castleman disease. Korean J Hematol 47:163–177
Bandera B, Ainsworth C, Shikle J, Rupard E, Roach M (2010) Treatment of unicentric Castleman disease with neoadjuvant rituximab. Chest 138:1239–1241
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sandrasegaran, K., Tomasian, A., Elsayes, K.M. et al. Hematologic malignancies of the pancreas. Abdom Imaging 40, 411–423 (2015). https://doi.org/10.1007/s00261-014-0217-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-014-0217-7